Histopathologic findings of retrieved specimens of vertebroplasty with polymethylmethacrylate cement: case control

Kuo-Yuan Huang1, Jing-Jou Yan, Ruey-Mo Lin

  • 1Department of Orthopedics, Institute of Clinical Medicine, National Cheng Kung University Medical Center, Taiwan.

Spine
|October 6, 2005
PubMed
Abstract

Insights

Polymethylmethacrylate (PMMA) cement used in vertebroplasty may cause adverse histopathologic changes, including bone necrosis and foreign body reactions. Further evaluation of long-term safety is recommended.

Area of Science:

  • Orthopedic surgery
  • Biomaterials science
  • Histopathology

Background:

  • Vertebroplasty with polymethylmethacrylate (PMMA) cement is a common treatment for vertebral compression fractures.
  • Concerns exist regarding the long-term outcomes and biocompatibility of PMMA cement.
  • Histopathologic changes associated with PMMA cement in vertebroplasty are infrequently reported.

Observation:

  • A case control study compared histopathologic findings of 2 PMMA-augmented vertebral bodies with 3 nonaugmented controls.
  • Key parameters assessed included bone necrosis, foreign body reaction, fibrotic wall formation, and neovascularization.

Findings:

  • PMMA cement was associated with peripheral bone necrosis and surrounding fibrotic tissue.
  • Foreign body reactions were observed exclusively in PMMA-augmented specimens.
  • Fibrotic wall formation and neovascularization were absent in PMMA-augmented cases but present in controls.

Implications:

  • The study suggests that PMMA cement may not be entirely bioinert.
  • Findings highlight the need for further investigation into the long-term safety and biocompatibility of PMMA cement in vertebroplasty.
  • These insights are crucial for refining surgical techniques and patient selection for vertebroplasty procedures.

Related Concept Videos